Business Context and Reporting Period
This Form 8-K Current Report was filed by Healthcare Trust of America, Inc. (NYSE: HTA) and its operating partnership, Healthcare Trust of America Holdings, LP, on September 15, 2020, regarding events occurring on September 14, 2020. The filing details a material definitive agreement for a new debt offering and a notice of redemption for existing senior notes.
Key Financial Metrics and Capital Structure
- New Debt Issuance: The Company entered into an underwriting agreement to issue $800.0 million in aggregate principal amount of 2.000% Senior Notes due 2031.
- Net Proceeds: The Offering is expected to generate approximately $786.9 million in net proceeds, excluding accrued interest and after deducting underwriting discounts and estimated offering expenses.
- Debt Redemption: The Company intends to use proceeds to redeem all outstanding 3.70% Senior Notes due 2023.
- Redemption Date: The 2023 Notes are scheduled to be redeemed on September 28, 2020.
- Redemption Price: The price will be determined based on the Adjusted Treasury Rate plus accrued and unpaid interest.
Material Changes and Use of Proceeds
The primary material change is the refinancing of existing debt. The net proceeds from the 2031 Notes will be allocated as follows:
- Redemption of all outstanding 3.70% Senior Notes due 2023.
- Repayment of a portion of the outstanding indebtedness under the Company's unsecured revolving credit and term loan facility.
- General corporate purposes, including working capital and investment in real estate.
The filing does not provide specific revenue, profit, cash flow, or margin figures for the reporting period, as this is a transactional filing rather than a periodic financial report.
Outlook, Risks, and Covenants
Covenants: The indenture for the 2031 Notes includes restrictive covenants, such as limitations on incurring additional indebtedness, requirements to maintain a pool of unencumbered assets, and mandates to maintain insurance with financially sound companies.
Risks and Forward-Looking Statements: The filing contains forward-looking statements regarding the consummation of the 2031 Notes offering and the 2023 Notes redemption. Actual results may differ materially due to risks identified in the Company's most recent Form 10-K and subsequent filings. The Company disclaims any obligation to update these statements.
Investor Verification Checklist
- Verify the final closing date and actual net proceeds of the $800 million 2031 Notes offering.
- Confirm the exact redemption price paid for the 2023 Notes based on the Adjusted Treasury Rate on the third business day prior to September 28, 2020.
- Review the updated debt maturity profile to assess the impact of replacing 2023 debt with 2031 debt.
- Examine the specific terms of the unsecured revolving credit and term loan facility to determine the exact amount of principal repaid.
- Check subsequent filings for any changes to the "Risk Factors" section related to the new debt covenants.